Details for New Drug Application (NDA): 206670
✉ Email this page to a colleague
NDA 206670 describes VECURONIUM BROMIDE, which is a drug marketed by Eugia Pharma, Gland, Hikma, Hospira, Meitheal, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharm, and Watson Labs, and is included in twelve NDAs. It is available from ten suppliers. Additional details are available on the VECURONIUM BROMIDE profile page.
The generic ingredient in VECURONIUM BROMIDE is vecuronium bromide. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.
The generic ingredient in VECURONIUM BROMIDE is vecuronium bromide. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.
Summary for 206670
| Tradename: | VECURONIUM BROMIDE |
| Applicant: | Eugia Pharma |
| Ingredient: | vecuronium bromide |
| Patents: | 0 |
Pharmacology for NDA: 206670
| Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Medical Subject Heading (MeSH) Categories for 206670
Suppliers and Packaging for NDA: 206670
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 206670 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1547 | 51662-1547-1 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (51662-1547-1) |
| VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 206670 | ANDA | Eugia US LLC | 55150-235 | 55150-235-11 | 10 VIAL in 1 CARTON (55150-235-11) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (55150-235-02) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/VIAL | ||||
| Approval Date: | Dec 20, 2018 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/VIAL | ||||
| Approval Date: | Dec 20, 2018 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
